315 related articles for article (PubMed ID: 15754263)
1. Mast cell chymase in the ischemic kidney of severe unilateral renovascular hypertension.
Morikawa T; Imanishi M; Suzuki H; Okada N; Okumura M; Konishi Y; Yoshioka K; Takai S; Miyazaki M
Am J Kidney Dis; 2005 Mar; 45(3):e45-50. PubMed ID: 15754263
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
3. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
[TBL] [Abstract][Full Text] [Related]
4. The influence of ACE-inhibition by captopril on renal formation and metabolism of angiotensins I and II in patients with renovascular hypertension.
Hesse B; Rasmussen S; Giese J; Nielsen MD; Høilund-Carlsen PF
Scand J Urol Nephrol Suppl; 1984; 79():45-8. PubMed ID: 6089318
[TBL] [Abstract][Full Text] [Related]
5. Renovascular hypertension with unilateral atherosclerotic renal artery occlusion: diagnostic use of renal vein renins.
Simon G; Limas CC; Miller RP
Angiology; 1982 Nov; 33(11):728-37. PubMed ID: 6753648
[TBL] [Abstract][Full Text] [Related]
6. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
Urata H; Boehm KD; Philip A; Kinoshita A; Gabrovsek J; Bumpus FM; Husain A
J Clin Invest; 1993 Apr; 91(4):1269-81. PubMed ID: 7682566
[TBL] [Abstract][Full Text] [Related]
7. Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features.
Rossi GP; Pavan E; Chiesura-Corona M; Bader M; Paganini G; Cesari M; De Toni R; Feltrin GP; Ganten D; Pessina AC
Clin Sci (Lond); 1997 Nov; 93(5):435-43. PubMed ID: 9486089
[TBL] [Abstract][Full Text] [Related]
8. Renovascular hypertension: clinical concepts.
Fenves AZ; Ram CV
Minerva Med; 2006 Aug; 97(4):313-24. PubMed ID: 17008836
[TBL] [Abstract][Full Text] [Related]
9. Plasma endothelin-1 level in patients with renovascular hypertension - does the kidney with stenosis of the renal artery upregulate production of endthelin-1?
Takeda M; Saito K; Tsutsui T; Mizusawa T; Obara K; Tomita Y; Takahashi K
Eur J Med Res; 1997 Jul; 2(7):315-20. PubMed ID: 9233908
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension].
Posadzy-Małaczyńska A
Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805
[TBL] [Abstract][Full Text] [Related]
11. Captopril-stimulated renal vein renin measurements in the diagnosis of atherosclerotic renovascular hypertension.
Simon G; Coleman CC
Am J Hypertens; 1994 Jan; 7(1):1-6. PubMed ID: 8136101
[TBL] [Abstract][Full Text] [Related]
12. A unique case of renovascular hypertension caused by combined renal artery disease.
Morimoto A; Nakatani A; Matsui K; Hashimoto T; Maeda M; Uchida H; Dohi K
Hypertens Res; 1995 Sep; 18(3):255-7. PubMed ID: 7584936
[TBL] [Abstract][Full Text] [Related]
13. Renovascular hypertension from segmental renal artery stenosis: importance of segmental renal vein renin sampling.
Lee SM; Drach GW
J Urol; 1980 Nov; 124(5):704-6. PubMed ID: 7005462
[TBL] [Abstract][Full Text] [Related]
14. Effect of chymase inhibitor on vascular proliferation.
Takai S; Miyazaki M
Jpn J Pharmacol; 2002 Nov; 90(3):223-7. PubMed ID: 12499576
[TBL] [Abstract][Full Text] [Related]
15. Observations on the use and limitations of renal vein renins in hypertensive patients.
Aurell M; Delin K; Granerus G
Contrib Nephrol; 1978; 11():146-9. PubMed ID: 699582
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting renal vein renin ratio in renal artery stenosis. Secretion of inactive renin.
Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Tillman DM; Webb DJ; Morton JJ; Robertson JI
Nephron; 1986; 44 Suppl 1():68-72. PubMed ID: 3018601
[TBL] [Abstract][Full Text] [Related]
17. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.
Doggrell SA; Wanstall JC
Cardiovasc Res; 2004 Mar; 61(4):653-62. PubMed ID: 14985062
[TBL] [Abstract][Full Text] [Related]
18. Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters.
Jin D; Takai S; Shiota N; Miyazaki M
J Hypertens; 1998 May; 16(5):657-64. PubMed ID: 9797177
[TBL] [Abstract][Full Text] [Related]
19. Improved diagnosis of unilateral renal artery lesions after captopril administration.
Thibonnier M; Joseph A; Sassano P; Guyenne TT; Corvol P; Raynaud A; Seurot M; Gaux JC
JAMA; 1984 Jan; 251(1):56-60. PubMed ID: 6361288
[TBL] [Abstract][Full Text] [Related]
20. The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man.
Kooner JS; Peart WS; Mathias CJ
Clin Auton Res; 1991 Sep; 1(3):195-204. PubMed ID: 1822252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
